Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 12/20 | 0.52 |
| ▸ | BACE2 | Q9Y5Z0 | 4/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.52 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.51 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.51 |
| ▸ | CTSD | P07339 | 1/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | NPY4R | P50391 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18905178 | 0.93 | KISS1R (0.48) | BACE1BACE2KISS1RNTSR2NTSR1 | |
| SCHEMBL18905179 | 0.93 | KISS1R (0.49) | BACE1BACE2KISS1RNTSR2NTSR1 | |
| SCHEMBL29857653 | 0.90 | NPY4R (0.59) | KISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL11886067 | 0.90 | NPY4R (0.59) | KISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL29458835 | 0.90 | NPY4R (0.59) | KISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL18910410 | 0.90 | KISS1R (0.49) | BACE1BACE2KISS1RNTSR2NTSR1 | |
| SCHEMBL29378886 | 0.87 | KISS1R (0.56) | BACE1BACE2KISS1RNTSR2NTSR1 | |
| SCHEMBL29857370 | 0.86 | NPY4R (0.61) | KISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL14706290 | 0.86 | KISS1R (0.54) | BACE1BACE2KISS1RNTSR2NTSR1 | |
| SCHEMBL29458713 | 0.86 | NPY4R (0.61) | KISS1RNPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170151163-A1 | HIGH-PERFORMANCE HAIR TREATMENT AGENTS WITH AN ANTI-WASHOUT EFFECT | HENKEL AG & CO. KGAA (DE) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170151163-A1 | HIGH-PERFORMANCE HAIR TREATMENT AGENTS WITH AN ANTI-WASHOUT EFFECT | OAT, CD44, FUT5 | BACE1 4425/4885BACE2 4724/4885KISS1R 3487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.